Evidence map›Paper›PMID 28546345›Full record

ArticleCirculation research2017

AIBP, NAXE, and Angiogenesis: What's in a Name?

Mary G Sorci-Thomas, Michael J Thomas

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.Current atherosclerosis reports · 2020
    Review
  6. [Clinical and genetic features of early-onset progressive encephalopathy associated with NAXE gene mutations].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mary G Sorci-ThomasFrom the Departments of Medicine, Section on Endocrinology (M.G.S.-T.) and Pharmacology and Toxicology (M.G.S.-T., M.J.T.), Medical College of Wisconsin, Milwaukee. msthomas@mcw.edu.
Michael J ThomasFrom the Departments of Medicine, Section on Endocrinology (M.G.S.-T.) and Pharmacology and Toxicology (M.G.S.-T., M.J.T.), Medical College of Wisconsin, Milwaukee.

Funding

T Regulatory Lymphocytes, HDL Function, and AtherosclerosisR01HL112276 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI HEDRICK, CATHERINE C, SORCI-THOMAS, MARY G · 2013 to 2016
$2.8M
Biophysics of HDL DysfunctionR01HL112270 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PRITCHARD, KIRKWOOD ARTHUR, SORCI-THOMAS, MARY G · 2012 to 2015
$2.5M
Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural ReorganizationR01HL127649 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SORCI-THOMAS, MARY G · 2015 to 2018
$2.2M
NHLBI NIH HHS R01 HL112270NHLBI NIH HHS R01 HL112276NHLBI NIH HHS R01 HL127649
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyloid Precursor Protein SecretasesSignal TransductionHumansNeovascularization, PathologicRacemases and EpimerasesTranscriptional ActivationUp-RegulationAmyloid Precursor Protein SecretasesNAXE protein, humanRacemases and EpimerasesAIBPapolipoprotein A-IcholesterolEditorialsNAXE

Identifiers

PMID28546345
PMCPMC5497770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.